Fig. 3From: Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case reportTimeline of patient clinical and laboratory findings. Unfractionated heparin at 5000U TID SubQ from Day 1–23; bivalirudin 250 mg [0.13 mg/kg/hr] + NaCl 0.9% (Infusion) from Day 23–32; Apixaban 5 mg BID from Day 32. SDH: Subdural hemorrhage; AMS: Altered mental status; CVST: cerebral venous sinus thrombosis; HIT: Heparin Induced Thrombocytopenia; SRA: serotonin release assay; PEA: P-selectin expression assay; PF4: Platelet Factor 4Back to article page